tiprankstipranks
Seelos Therapeutics (SEELQ)
OTHER OTC:SEELQ
US Market
SEELQ
Seelos Therapeutics
RESEARCH TOOLSreports
Want to see SEELQ full AI Analyst Report?

Seelos Therapeutics (SEELQ) Financial Statements

1,201 Followers

Seelos Therapeutics Financial Overview

Seelos Therapeutics's market cap is currently $112.00. The company's EPS TTM is $; its P/E ratio is ―; Seelos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 2.20M---$ 151.00K
Operating Income$ -40.50M$ -70.92M$ -61.67M$ -18.76M$ -34.99M
EBITDA$ -37.75M$ -73.47M$ -64.45M$ -18.94M$ -51.23M
Net Income$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 5.42M$ 22.75M$ 83.50M$ 17.49M$ 11.10M
Total Debt$ 14.23M$ 20.12M$ 18.96M$ 9.72M$ 0.00
Net Debt$ 11.23M$ 4.59M$ -59.78M$ -5.94M$ -10.26M
Total Liabilities$ 38.93M$ 33.36M$ 26.18M$ 14.92M$ 11.10M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -23.91M$ -61.60M$ -48.99M$ -20.91M$ -19.30M
Operating Cash Flow$ -23.91M$ -61.60M$ -48.99M$ -20.91M$ -19.30M
Investing Cash Flow
Financing Cash Flow

Seelos Therapeutics Earnings and Revenue History

Income Statement >

Seelos Therapeutics Debt to Assets

Balance Sheet >

Seelos Therapeutics Cash Flow

Cash Flow >

Seelos Therapeutics Forecast EPS vs Actual EPS

Earnings >